Cargando…
Association of P2Y12 Gene Promoter DNA Methylation with the Risk of Clopidogrel Resistance in Coronary Artery Disease Patients
Background. Clopidogrel inhibits the ADP receptor P2Y12 to keep down the platelet aggregation. The goal of our study is to investigate the contribution of P2Y12 promoter DNA methylation to the risk of clopidogrel resistance (CR). Methods. The platelet functions were measured by the VerifyNow P2Y12 a...
Autores principales: | Su, Jia, Li, Xiaojing, Yu, Qinglin, Liu, Yahui, Wang, Yaqing, Song, Haojun, Cui, Hanbin, Du, Weiping, Fei, Xiaohong, Liu, Junsong, Lin, Shaoyi, Wang, Jian, Zheng, Wenyuan, Zhong, Jinyan, Zhang, Lulu, Tong, Maoqing, Xu, Jin, Chen, Xiaomin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3976931/ https://www.ncbi.nlm.nih.gov/pubmed/24745016 http://dx.doi.org/10.1155/2014/450814 |
Ejemplares similares
-
The risk of clopidogrel resistance is associated with ABCB1 polymorphisms but not promoter methylation in a Chinese Han population
por: Su, Jia, et al.
Publicado: (2017) -
Clopidogrel Resistance Is Associated With DNA Methylation of Genes From Whole Blood of Humans
por: Yang, Jin, et al.
Publicado: (2021) -
Association of PON1 gene promoter DNA methylation with the risk of Clopidogrel resistance in patients with coronary artery disease
por: Su, Jia, et al.
Publicado: (2019) -
Associations of PER3 polymorphisms with clopidogrel resistance among Chinese Han people treated with clopidogrel
por: Zheng, Nan, et al.
Publicado: (2021) -
Conditioned medium from bone marrow-derived mesenchymal stem cells inhibits vascular calcification through blockade of the BMP2–Smad1/5/8 signaling pathway
por: Wang, Shuangshuang, et al.
Publicado: (2018)